RECRUITING

Implementation of a ColoRectal Cancer Screening Tool in US Primary Care Practices - Usual Quality Improvement (10 Clinics) vs Normalization Process Theory-Participatory Learning in Action (10 Clinics)

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

Although implementation intentions (I2)-based tools enhance colorectal cancer (CRC) screening uptake, prior studies have not tested their implementation into routine primary care delivery. In this study, investigators will conduct a cluster-randomized trial in 20 US primary care clinics. Specific aims for the project will be: 1) to test whether a Normalization Process Theory-informed Participatory Learning in Action (NPT-PLA intervention) implementation of a proven implementation Intentions-based colorectal cancer screening tool ("I2") improves screening uptake (i.e. screening order and completion) within 6 months of patient enrollment versus usual quality improvement (control) implementation; and 2) to evaluate the facilitators and barriers of each implementation arm using the 2022 expanded Normalization Process Theory (NPT) framework. Multi-disciplinary clinic 'implementation teams' that include clinic staff and patients whose preferred language is Spanish will meet monthly during the first 6 months of clinic participation and aim to integrate into routine primary care the "I2" CRC screening tool, using the NPT-PLA intervention or control approach. The I2 tool addresses the "when," "where" and "how" details of stool sample or colonoscopy screening. The I2 tool will be delivered via an on-line survey or (if patients prefer) by paper form customized for use in English or Spanish. At least 100 patients in each clinic will be enrolled in the first 6 months of clinic participation (2000 in total). All patients eligible for CRC screening will be offered the I2 tool. Their choices will be communicated automatically to clinics for order entry. Primary (Aim 1) outcomes will be CRC screening orders placed (by clinic staff); completion of the I2 tool and CRC screening completion (by patients) over 6 months of patient follow-up. For Aim 2, surveys based on the NPT domains (the "NOMAD") will be used to assess staff comprehension of their role in implementing the I2-based CRC screening tool, its salience, their buy-in, feasibility of altering workflows, and the potential impact of using the tool in their setting. Investigators will conduct summative qualitative focus group discussions in all participating clinics after 6 months of clinic participation. The study will provide important information on barriers and facilitators of embedding NPT-PLA interventions in "real-world" primary care clinical settings.

Official Title

PB-iCRC: Multi-site Practice-Based Implementation of a ColoRectal Cancer Screening Intervention

Quick Facts

Study Start:2024-11-30
Study Completion:2029-04-30
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT06682650

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:45 Years to 75 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:Yes
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. Age 18 years or older
  2. Willing and able to provide informed consent
  3. Able to understand and follow study procedures
  4. Stable medical condition
  1. * patients ineligible for routine screening based on a personal or close family history of colorectal cancer or who have increased genetic risk of colon cancer.
  2. * cognitive or decisional incapacity will be excluded from the implementation teams, after completion of a brief, validate screening tool, the Mini-Cog Exam.

Contacts and Locations

Study Contact

Joseph W LeMaster, MD MPH
CONTACT
573-999-3366
jlemaster@kumc.edu
Traci Buechner
CONTACT
715-661-2422
tbuechner@kumc.edu

Principal Investigator

Joseph W LeMaster, MD MPH
PRINCIPAL_INVESTIGATOR
University of Kansas
Christina Hester, PhD
PRINCIPAL_INVESTIGATOR
DARTNet Institute
Keith A Greiner, MD MPH
PRINCIPAL_INVESTIGATOR
University of Kansas

Study Locations (Sites)

DARTNet Institute
Aurora, Colorado, 80045
United States

Collaborators and Investigators

Sponsor: University of Kansas Medical Center

  • Joseph W LeMaster, MD MPH, PRINCIPAL_INVESTIGATOR, University of Kansas
  • Christina Hester, PhD, PRINCIPAL_INVESTIGATOR, DARTNet Institute
  • Keith A Greiner, MD MPH, PRINCIPAL_INVESTIGATOR, University of Kansas

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2024-11-30
Study Completion Date2029-04-30

Study Record Updates

Study Start Date2024-11-30
Study Completion Date2029-04-30

Terms related to this study

Keywords Provided by Researchers

  • colorectal carcinoma
  • implementation science
  • cancer prevention
  • cancer screening
  • normalization process theory
  • participatory health research
  • cluster randomized trial

Additional Relevant MeSH Terms

  • Colorectal Carcinoma